Skip to content

Clinical trials

Phase 2 Bronchiolitis Obliterans Syndrome trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 2 Country / region: Italy Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20153
20201
20212
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting4
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation3
Novartis Pharmaceuticals3
Celgene1
ElectroCore INC1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
Sanofi1
Syndax Pharmaceuticals1
University of Milano Bicocca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome12
Leukemia4
Graft vs Host Disease2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Bone Marrow Diseases1
Bronchiolitis Obliterans1
Cluster Headache1
Hematologic Diseases1
Leukemia, Lymphocytic, Chronic, B-Cell1
Lymphoma, Follicular1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.